Adults living with diabetes in the United States reported highest satisfaction using Roche Diabetes Care's ACCU-CHEK products compared with other blood glucose meter manufacturers, according to the inaugural J.D. Power and Associates 2012 Blood Glucose Meter Satisfaction StudySM. Diabetes affects a large portion of the U.S. population – 25.8 million children and adults or approximately 1 in 12 people.
UT Dallas researchers are extending the borders of virtual reality, going beyond virtual spaces in which people can see and hear one another to an environment that adds the sense of touch.
For years the trends have been clear: not only are we getting older all the time, but we are also increasingly left to take care of ourselves in our old age. This is why researchers are already working on technologies that will assist us in everyday situations later in life. One of these technologies is will be presented by the Fraunhofer Institute for Integrated Circuits IIS in Erlangen (Germany) at the CeBIT trade fair in Hanover, March 5-9, 2013 (Hall 9, stand E08): an intelligent armchair we can not only comfortably sink into in front of the television but one that also motivates us to keep ourselves healthy and fit.
Three teams, including the first all-undergraduate team to place, earned a total of $140,000 during the annual Olin Cup commercial business plan competition finals Jan. 30 in Simon Hall.
On the tails of CES, global media communications agency Havas Media released today a video exploring one of the hottest trends for consumers and marketers today: Life Tracking and the Quantified Self. Through today's technologies, life tracking allows people to measure and monitor the activities in their daily lives, from eating and sleeping to exercising and shopping.
Breezing, a new startup based on technology developed by researchers at Arizona State University, is offering the world's first portable device that can track an individual's metabolism and use that information to provide diet and exercise recommendations for maintaining or reaching a healthy weight.
Nonin Medical, Inc., the inventor of finger pulse oximeters and a leader in noninvasive medical monitoring, announced today that the company has donated six Onyx® 9500 finger pulse oximeters to the Evangelistic International Ministries (EIM) for use at the Hospital Centro Socorro De Lo Alto in the remote village of Sula, Honduras.
Joint replacements have a limited lifespan. Implant wear is usually to blame for the necessary revision surgery. Despite new breakthroughs in the development of advanced polyethylene, longer life-spans and active patient lifestyles have compromised the life-span of the artificial joint. However, according to a study presented at the Orthopaedic Research Society's 2013 Annual Meeting in San Antonio this month, it appears that the intensity of activity has more impact on implant wear than previously believed.
Masimo returns to Arab Health Jan. 28-31, the world's longest running healthcare exhibition and congress held each year in Dubai, UAE, to showcase advanced, noninvasive patient monitoring technologies – including breakthrough SET® Measure-Through Motion pulse oximetry and rainbow® Pulse CO-Oximetry® – that are becoming the standard-of-care across the Middle East.
Attention Deficit Hyperactivity Disorder (ADHD) is the most common childhood neuropsychiatric disorder. Yet there is currently no tool that will confirm the diagnosis of ADHD. In her thesis entitled “Development of a genotyping system to be applied in Attention Deficit Hyperactivity Disorder and its Pharmacogenetics" (“Desarrollo de un sistema de genotipado para la aplicación en el ‘trastorno por déficit de atención con hiperactividad’ y su farmacogenética”), the researcher Alaitz Molano, a graduate in biochemistry and PhD holder in Pharmacology from the UPV/EHU-University of the Basque Country, presents a tool that could improve not only the diagnosis of but also the therapeutics for this disorder.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.